Detalhe da pesquisa
1.
Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction.
Am Heart J
; 266: 188-197, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648579
2.
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
N Engl J Med
; 381(14): 1309-1320, 2019 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31475798
3.
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Lancet
; 394(10204): 1169-1180, 2019 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31484629
4.
Safety and Cumulative Incidence of Major Cardiovascular Events with Ticagrelor in Taiwanese Patients with Non-ST-Segment Elevation Myocardial Infarction: A 12-Month, Prospective, Phase IV, Multicenter, Single-Arm Study.
Acta Cardiol Sin
; 36(3): 195-206, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32425434
5.
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure.
NEJM Evid
; 3(2): EVIDoa2300286, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320489
6.
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis.
J Am Coll Cardiol
; 83(17): 1627-1636, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658101
7.
Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial.
Eur Heart J Cardiovasc Pharmacother
; 8(8): 777-785, 2022 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488865
8.
The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure lowering.
J Thromb Thrombolysis
; 32(4): 399-404, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21614456
9.
Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials.
J Am Coll Cardiol
; 77(19): 2366-2377, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33985681
10.
Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study.
Clin Cardiol
; 42(5): 498-505, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30788847
11.
Prolonged cyclic strain impairs the fibrinolytic system in cultured vascular endothelial cells.
J Hypertens
; 23(8): 1551-7, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16003182
12.
Profibrinolytic effect of the epigenetic modifier valproic acid in man.
PLoS One
; 9(10): e107582, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25295869
13.
Does the timing of treatment with intra-aortic balloon counterpulsation in cardiogenic shock due to ST-elevation myocardial infarction affect survival?
Acute Card Care
; 16(2): 57-62, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24670205
14.
Impaired capacity for stimulated fibrinolysis in primary hypertension is restored by antihypertensive therapy.
Hypertension
; 47(4): 686-91, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16520399